3/20/2023 6:41:17 AM
Karuna Therapeutics Reports Positive Results From Phase 3 EMERGENT-3 Trial Of KarXT In Schizophrenia
11/9/2021 7:43:37 AM
Karuna And Zai Lab Collaborate For Development, Manufacturing, And Commercialization Of KarXT In Greater China
8/9/2019 7:39:56 AM
Wedbush Is Raising Karuna Therapeutics, Inc. (KRTX) FY20 Estimate To -2.77 From -3.10
8/9/2019 7:39:44 AM
Wedbush Is Raising Karuna Therapeutics, Inc. (KRTX) Q4 20 Estimate To -0.77 From -0.86
8/9/2019 7:39:32 AM
Wedbush Is Increasing Karuna Therapeutics, Inc. (KRTX) Q3 20 Estimate To -0.75 From -0.84
8/9/2019 7:39:18 AM
Wedbush Is Raising Karuna Therapeutics, Inc. (KRTX) Q2 20 Estimate To -0.68 From -0.77
8/9/2019 7:39:04 AM
Wedbush Is Increasing Karuna Therapeutics, Inc. (KRTX) Q1 20 Estimate To -0.57 From -0.63
8/9/2019 7:38:52 AM
Wedbush Is Raising Karuna Therapeutics, Inc. (KRTX) FY19 Estimate To -2.20 From -3.20
8/9/2019 7:38:40 AM
Wedbush Is Raising Karuna Therapeutics, Inc. (KRTX) Q3 19 Estimate To -0.47 From -0.65
8/9/2019 7:38:14 AM
Wedbush Reiterates Karuna Therapeutics, Inc. (KRTX) At Outperform With $38 Price Target
7/23/2019 8:52:54 AM
Wedbush Initiates Karuna Therapeutics, Inc. (KRTX) At Outperform With $38 Price Target